^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

CD276 expression

i
Other names: CD276, CD276 Molecule, CD276 Antigen, B7 Homolog 3, B7-H3, B7RP-2
Entrez ID:
Related biomarkers:
Phase 1
Seattle Children's Hospital
Recruiting
Last update posted :
12/20/2023
Initiation :
12/11/2019
Primary completion :
05/01/2026
Completion :
05/01/2041
CD276
|
CD276 expression
|
SCRI-CARB7H3(s)
Phase 1/2
Dushu Lake Hospital Affiliated to Soochow Unive...
Recruiting
Last update posted :
08/30/2023
Initiation :
06/01/2023
Primary completion :
12/31/2025
Completion :
12/31/2026
IL6 • CD276 • IL10
|
CD276 expression
|
QH104
Phase 1
St. Jude Children's Research Hospital
Recruiting
Last update posted :
08/08/2023
Initiation :
07/06/2022
Primary completion :
03/01/2026
Completion :
03/01/2027
CD276
|
CD276 expression
|
cyclophosphamide • fludarabine IV • B7-H3 CAR-T
Phase N/A
Peking University People's Hospital
Recruiting
Last update posted :
07/12/2023
Initiation :
06/05/2023
Primary completion :
07/01/2024
Completion :
12/31/2024
CD276
|
CD276 expression
Phase 1
Seattle Children's Hospital
Active, not recruiting
Last update posted :
07/10/2023
Initiation :
07/13/2020
Primary completion :
12/01/2025
Completion :
12/01/2040
CD276
|
CD276 expression • CD19 expression
|
Keytruda (pembrolizumab) • SCRI-CARB7H3(s) • SCRI-CARB7H3(s)x19 • SCRI-huCAR19v1
Phase 1
Second Affiliated Hospital of Guangzhou Medical...
Recruiting
Last update posted :
02/28/2023
Initiation :
05/01/2022
Primary completion :
05/01/2025
Completion :
05/01/2025
EGFR • CD276
|
EGFR expression • CD276 expression
|
Undisclosed EGFR/B7H3 CAR-T
Phase 1
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Recruiting
Last update posted :
02/16/2023
Initiation :
09/26/2022
Primary completion :
09/26/2023
Completion :
09/26/2025
CD276
|
CD276 expression
|
UTAA06
Phase 1
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Recruiting
Last update posted :
02/10/2023
Initiation :
12/27/2022
Primary completion :
12/27/2023
Completion :
12/27/2024
CD276
|
CD276 expression
|
UTAA06
Phase 1
MacroGenics
Completed
Last update posted :
05/19/2022
Initiation :
02/27/2018
Primary completion :
04/27/2022
Completion :
04/27/2022
CD276
|
PD-L1 expression • CD276 expression
|
Zynyz (retifanlimab-dlwr) • orlotamab (MGD009)
Phase 1/2
The Affiliated Hospital of Xuzhou Medical Unive...
Recruiting
Last update posted :
04/12/2022
Initiation :
02/10/2022
Primary completion :
02/10/2024
Completion :
02/10/2027
CD276
|
CD276 expression
|
cyclophosphamide • fludarabine IV • fhB7H3.CAR-Ts
Phase 1
MacroGenics
Completed
Last update posted :
02/08/2022
Initiation :
12/01/2016
Primary completion :
05/22/2019
Completion :
05/22/2019
CD276
|
CD276 expression
|
enoblituzumab (MGA271)
Phase 1
MacroGenics
Completed
Last update posted :
02/08/2022
Initiation :
03/26/2015
Primary completion :
11/09/2017
Completion :
09/26/2018
CD276
|
CD276 expression
|
Yervoy (ipilimumab) • enoblituzumab (MGA271)
Phase 1/2
The Affiliated Hospital of Xuzhou Medical Unive...
Recruiting
Last update posted :
01/27/2022
Initiation :
11/16/2021
Primary completion :
08/31/2023
Completion :
08/31/2026
CD276 • MUC16
|
CD276 expression
|
cyclophosphamide • fhB7H3.CAR-Ts
Phase 1/2
Shenzhen University General Hospital
Recruiting
Last update posted :
12/03/2021
Initiation :
07/01/2021
Primary completion :
06/01/2024
Completion :
07/01/2024
CD276 • BRCA
|
CD276 expression
|
CD276 CAR-T
Phase 1
MacroGenics
Completed
Last update posted :
09/28/2021
Initiation :
07/01/2015
Primary completion :
08/18/2021
Completion :
08/18/2021
CD276
|
CD276 expression
|
Keytruda (pembrolizumab) • cisplatin • Zynyz (retifanlimab-dlwr) • enoblituzumab (MGA271)
Phase 1
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Not yet recruiting
Last update posted :
05/06/2021
Initiation :
05/14/2021
Primary completion :
05/14/2022
Completion :
05/14/2023
CD276
|
CD276 expression
|
TAA6-CAR-T